GeoVax Labs Inc GOVX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:36 PM EDT
5.95UNCH (UNCH)
Volume
1,615
Close
5.95quote price arrow down-0.35 (-5.56%)
Volume
491,415
52 week range
2.56 - 35.00

...

Loading . . .
  • Open5.81
  • Day High6.09
  • Day Low5.56
  • Prev Close6.30
  • 52 Week High35.00
  • 52 Week High Date07/22/20
  • 52 Week Low2.56
  • 52 Week Low Date11/24/20

Key Stats

  • Market Cap37.60M
  • Shares Out6.32M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • YTD % Change76.04

KEY STATS

  • Open5.81
  • Day High6.09
  • Day Low5.56
  • Prev Close6.30
  • 52 Week High35.00
  • 52 Week High Date07/22/20
  • 52 Week Low2.56
  • 52 Week Low Date11/24/20
  • Market Cap37.60M
  • Shares Out6.32M
  • 10 Day Average Volume0.64M
  • Dividend-
  • Dividend Yield-
  • Beta1.73
  • YTD % Change76.04

RATIOS/PROFITABILITY

  • EPS (TTM)-4.34
  • P/E (TTM)-1.37
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-2.797M
  • ROE (MRQ)-98.84%
  • Revenue (MRQ)1.82M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-162.20%
  • Debt To Equity (MRQ)2.07%

EVENTS

  • Earnings Date08/16/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GeoVax Labs Inc

There is no recent news for this security.

Profile

MORE
GeoVax Labs, Inc. (GeoVax) is a clinical-stage biotechnology company. The Company is engaged in developing human vaccines against infectious diseases using its modified vaccine Ankara-virus-like particles (MVA-VLP) vaccine platform. The Company's platform supports in vivo expression of non-infectious virus-like particles (VLPs) from the cells of the person receiving the vaccine. The Company's development programs are focused on vaccines against Human Immunodeficiency Virus...
David Dodd
Chairman
Mark Reynolds CPA
Chief Financial Officer
Address
1900 Lake Park Drive, Suite 380
Smyrna, GA
30080
United States

Top Peers

SYMBOLLASTCHG%CHG
PALI
Palisade Bio Inc
5.97+0.26+4.55%
HOTH
Hoth Therapeutics Inc
1.48-0.02-1.33%
XBIO
Xenetic Biosciences Inc
1.86+0.02+1.09%
MLND
Millendo Therapeutics Inc
1.09-0.02-1.80%
PSTV
Plus Therapeutics Inc
2.17-0.09-3.98%